Addex Therapeutics Ltd ADR (ADXN) Stock Price, Quote & News

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate re...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 22 884 1555

Fax: 41 22 884 1556

Website: www.addextherapeutics.com

Address:

Chemin des Mines, 9, Geneva, Switzerland

ElevenXProfits Feb. 26 at 8:40 PM

$ADXN Added a lotto before the volume spikes, Very tiny float just needs news and she goes double digits

0 · Reply

TheMorningStew Feb. 24 at 10:30 AM

$ADXN will get a pump to 10+ eventually - 1.2M float

0 · Reply

OfficialStocktwitsUser Feb. 19 at 2:27 PM

$ADXN RSI: 39.64, MACD: -0.1477 Vol: 0.26, MA20: 7.78, MA50: 7.90 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

OfficialStocktwitsUser Feb. 19 at 3:27 AM

$ADXN RSI: 39.64, MACD: -0.1477 Vol: 0.26, MA20: 7.78, MA50: 7.90 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

MarketSniff Feb. 9 at 11:44 AM

$ADXN is a biotech (Addex Therapeutics) focused on allosteric modulators for neurological disorders; CNS drug development is notoriously difficult due to the blood-brain barrier and subjective endpoints.

0 · Reply

flybyme Feb. 3 at 3:51 PM

$ADXN And what happened nothing. Oh well same old story for years.

0 · Reply

flybyme Feb. 3 at 3:51 PM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-announces-publication-preclinical-data-supporting-potential-mglu7-negative-allosteric-modulators-transform-anxiety-and-fea/

0 · Reply

BenKaitz Jan. 13 at 5:34 PM

$ADXN halted while going up

0 · Reply

astro_zombie Jan. 13 at 5:20 PM

$ADXN wtf is going on here?

0 · Reply

Mrious Jan. 13 at 5:18 PM

$ADXN HALTED low volume. Let’s see what this does. $AHMA

0 · Reply

Addex Therapeutics (ADXN) Publishes Promising Research on Anxiety Treatment

2026-01-07T10:26:34.000Z - 2 months ago

Addex Therapeutics (ADXN) Advances NTX-253 into Clinical Trials for Schizophrenia

Wed, 07 Jan 2026 01:00:00 -0500 - 2 months ago

Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Thu, 11 Dec 2025 01:00:00 -0500 - 3 months ago

Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.

2025-12-04T23:06:42.000Z - 3 months ago

Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ...

2025-12-04T22:03:09.000Z - 3 months ago

Q3 2025 Addex Therapeutics Ltd Earnings Call Transcript

Thu, 04 Dec 2025 13:38:50 -0500 - 3 months ago

Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript

2025-12-04T11:11:11.000Z - 3 months ago

Earnings Scheduled For December 4, 2025

Thu, 04 Dec 2025 01:00:00 -0500 - 3 months ago

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Mon, 01 Dec 2025 01:00:00 -0500 - 3 months ago

Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025

2025-10-01T21:01:16.000Z - 5 months ago

Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ...

2025-10-01T20:01:07.000Z - 5 months ago

Q2 2025 Addex Therapeutics Ltd Earnings Call Transcript

Wed, 01 Oct 2025 13:52:07 -0400 - 5 months ago

Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Transcript

2025-09-30T08:32:10.000Z - 5 months ago

Earnings Scheduled For September 30, 2025

2025-09-30T07:34:43.000Z - 5 months ago

Addex Therapeutics Slips To Q2 Net Loss With Lower Income

Tue, 30 Sep 2025 01:00:00 -0400 - 5 months ago

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Fri, 26 Sep 2025 01:00:00 -0400 - 6 months ago

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

Tue, 23 Sep 2025 01:00:00 -0400 - 6 months ago

Addex Appoints Bank of New York Mellon as Depositary Bank

2025-09-12T09:19:19.000Z - 6 months ago

Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket

2025-09-01T08:32:07.000Z - 6 months ago

Earnings Scheduled For September 1, 2025

Mon, 30 Jun 2025 01:00:00 -0400 - 9 months ago

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs

Mon, 30 Jun 2025 01:00:00 -0400 - 9 months ago

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Wed, 25 Jun 2025 01:00:00 -0400 - 9 months ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

2025-06-19T08:32:07.000Z - 9 months ago

Earnings Scheduled For June 19, 2025

Thu, 19 Jun 2025 01:00:00 -0400 - 9 months ago

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Wed, 18 Jun 2025 01:00:00 -0400 - 9 months ago

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Fri, 06 Jun 2025 01:00:00 -0400 - 10 months ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Tue, 03 Jun 2025 01:00:00 -0400 - 10 months ago

Addex Convenes Annual General Meeting 2025

Mon, 12 May 2025 01:00:00 -0400 - 11 months ago

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Wed, 30 Apr 2025 01:00:00 -0400 - 11 months ago

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Fri, 25 Apr 2025 16:40:20 -0400 - 11 months ago

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Fri, 25 Apr 2025 01:00:00 -0400 - 11 months ago

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Thu, 17 Apr 2025 01:00:00 -0400 - 11 months ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Wed, 08 Jan 2025 01:00:00 -0500 - 1 year ago

Addex to Present at the 2025 Swiss Equities Baader Conference

2024-11-23T07:01:52.000Z - 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...

2024-11-22T23:02:33.000Z - 1 year ago

Q3 2024 Addex Therapeutics Ltd Earnings Call Transcript

Fri, 22 Nov 2024 11:11:38 -0500 - 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Fri, 22 Nov 2024 01:00:00 -0500 - 1 year ago

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mon, 11 Nov 2024 01:00:00 -0500 - 1 year ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

2024-10-01T07:00:37.000Z - 1 year ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...

2024-10-01T05:00:23.000Z - 1 year ago

Q2 2024 Addex Therapeutics Ltd Earnings Call Transcript

Mon, 30 Sep 2024 12:04:08 -0400 - 1 year ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Mon, 30 Sep 2024 01:00:00 -0400 - 1 year ago

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 19, 2024, 1:00 AM EDT - 1 year ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Sep 4, 2024, 1:00 AM EDT - 1 year ago

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 12:03 PM EDT - 1 year ago

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Aug 27, 2024, 10:47 AM EDT - 1 year ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 1:00 AM EDT - 1 year ago

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Jul 22, 2024, 1:00 AM EDT - 1 year ago

Addex's Partner Discontinues ADX71149 development in Epilepsy

Jul 15, 2024, 1:00 AM EDT - 1 year ago

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Jul 12, 2024, 1:00 AM EDT - 1 year ago

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Jun 6, 2024, 12:50 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Jun 6, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Jun 5, 2024, 1:00 AM EDT - 1 year ago

Addex Convenes Annual General Meeting 2024

May 31, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

May 8, 2024, 1:00 AM EDT - 2 years ago

Addex to Present at Bio€quity Europe 2024

Apr 29, 2024, 1:00 AM EDT - 2 years ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 19, 2024, 1:00 AM EDT - 2 years ago

Addex to Present at the Swiss Biotech Day 2024

Apr 18, 2024, 1:46 PM EDT - 2 years ago

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Apr 18, 2024, 1:00 AM EDT - 2 years ago

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Apr 11, 2024, 1:00 AM EDT - 2 years ago

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Apr 3, 2024, 1:00 AM EDT - 2 years ago

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Mar 14, 2024, 2:00 AM EDT - 2 years ago

Addex to Present at the Bio-Europe Spring 2024 Conference

Jan 31, 2024, 1:00 AM EST - 2 years ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Jan 9, 2024, 1:00 AM EST - 2 years ago

Addex to Present at the Swiss Equities Baader Conference

Jan 5, 2024, 1:30 AM EST - 2 years ago

Addex to Present at Biotech Showcase™ 2024

ElevenXProfits Feb. 26 at 8:40 PM

$ADXN Added a lotto before the volume spikes, Very tiny float just needs news and she goes double digits

0 · Reply

TheMorningStew Feb. 24 at 10:30 AM

$ADXN will get a pump to 10+ eventually - 1.2M float

0 · Reply

OfficialStocktwitsUser Feb. 19 at 2:27 PM

0 · Reply

OfficialStocktwitsUser Feb. 19 at 3:27 AM

0 · Reply

MarketSniff Feb. 9 at 11:44 AM

0 · Reply

flybyme Feb. 3 at 3:51 PM

$ADXN And what happened nothing. Oh well same old story for years.

0 · Reply

flybyme Feb. 3 at 3:51 PM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-announces-publication-preclinical-data-supporting-potential-mglu7-negative-allosteric-modulators-transform-anxiety-and-fea/

0 · Reply

BenKaitz Jan. 13 at 5:34 PM

$ADXN halted while going up

0 · Reply

astro_zombie Jan. 13 at 5:20 PM

$ADXN wtf is going on here?

0 · Reply

Mrious Jan. 13 at 5:18 PM

$ADXN HALTED low volume. Let’s see what this does. $AHMA

0 · Reply

MarketClarityX Dec. 27 at 6:27 AM

$ADXN Investor attention is skewing toward repeatable operating performance instead of aspirational projections. Resource allocation choices will signal strategic maturity. Transparency improvements could narrow valuation spreads. As performance stabilizes, the path forward can strengthen.

0 · Reply

ALRAE Dec. 22 at 1:32 AM

0 · Reply

flybyme Dec. 12 at 9:55 AM

$ADXN Where have all the pumpers gone, they will be back in a coupel of months, as always.

0 · Reply

flybyme Dec. 11 at 3:34 PM

$ADXN more dilution on nothing https://www.addextherapeutics.com/en/investors/press-releases/addex-amends-its-market-offering-agreement-hc-wainwright-co/

0 · Reply